These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 12731640)

  • 21. Vigabatrin in the treatment of infantile spasms.
    Koo B
    Pediatr Neurol; 1999 Feb; 20(2):106-10. PubMed ID: 10082337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin.
    Cohen-Sadan S; Kramer U; Ben-Zeev B; Lahat E; Sahar E; Nevo Y; Eidlitz T; Zeharia A; Kivity S; Goldberg-Stern H
    Eur J Neurol; 2009 Apr; 16(4):482-7. PubMed ID: 19348622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study.
    Lagae L; Verhelst H; Ceulemans B; De Meirleir L; Nassogne MC; De Borchgrave V; D'Hooghe M; Foulon M; Van Bogaert P
    Seizure; 2010 Apr; 19(3):159-64. PubMed ID: 20149693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infantile spasms: therapy and outcome.
    Riikonen R
    J Child Neurol; 2004 Jun; 19(6):401-4. PubMed ID: 15446386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopmental and epilepsy outcomes of patients with infantile spasms treated in a tertiary care center.
    Bashiri FA; Al-Sehemi MA; Hamad MH; Alshammari NR; Aljumah MA; Kentab A; Salih MA
    Neurosciences (Riyadh); 2021 Jan; 26(1):21-25. PubMed ID: 33530039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic trial of vigabatrin in refractory infantile spasms.
    Chiron C; Dulac O; Beaumont D; Palacios L; Pajot N; Mumford J
    J Child Neurol; 1991; Suppl 2():S52-9. PubMed ID: 1940125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms.
    Granström ML; Gaily E; Liukkonen E
    Epilepsia; 1999 Jul; 40(7):950-7. PubMed ID: 10403219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study.
    Cossette P; Riviello JJ; Carmant L
    Neurology; 1999 May; 52(8):1691-4. PubMed ID: 10331702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pharmacotherapy of infantile spasms.
    Riikonen R
    CNS Drugs; 2014 Apr; 28(4):279-90. PubMed ID: 24504827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of infantile spasms.
    Hancock E; Osborne JP; Milner P
    Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up study of vigabatrin in pretreated children with West syndrome.
    Siemes H; Brandl U; Spohr HL; Völger S; Weschke B
    Seizure; 1998 Aug; 7(4):293-7. PubMed ID: 9733404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.